Form D · Other Technology
BioSked, Inc.
Fairport, NY · CIK 0001896639
Offering snapshot reported Sep 11, 2025 · SEC filing
- Reported sold
- $123K Offering amount: $1.7M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Aug 31, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 11, 2025 | Initial | $122,756 | No comparison | 1 | SEC filing |
| Jan 3, 2022 | Initial | $850,000 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0 (estimated)
- Finders' fees
- $0 (estimated)
- Form D file number
- 021-557277
Source: Form D, filed Sep 11, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Timothy Daly | Director, Executive |
| David Dudok De Wit | Director, Executive |
| Daniel Kerpelman | Director |
| Thomas Le Dall | Director, Executive |
| Sarah Mertz | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
770 Ayrault Road Suite 93
Fairport, NY, 14450
Fairport, NY, 14450